Skip to content
  • Saturday, 12 September 2026
  • 6:58 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 16, 2026 0

Chinese researchers have unveiled a groundbreaking approach to treating ocular cancers, specifically retinoblastoma, through the development of specialized eye drops…

Read More
Biotech & Genetic Research

AI-Engineered Smart Proteins Revolutionize Biosensing for Medicine, Environment, and Biotechnology

Jia Lissa Apr 16, 2026 0

An international team of researchers, spearheaded by scientists at Queensland University of Technology (QUT) in Brisbane, Australia, has unveiled a…

Read More
Advanced Materials Science

Engineered Mie Voids in Bismuth Telluride Heterostructures Enable Enhanced Light-Matter Interactions in Atomically Thin Semiconductors

Nila Kartika Wati Apr 12, 2026 0

The field of nanophotonics has reached a significant milestone with the development of a novel strategy to amplify light emission…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 9, 2026 0

Researchers in China have achieved a significant breakthrough in ophthalmic pharmacology, developing innovative eye drops derived from pig semen that…

Read More
Laboratory Automation & Robotics

Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery

Lana Keisha Apr 2, 2026 0

In a groundbreaking development that could revolutionize the treatment of ocular cancers, researchers in China have successfully engineered eye drops…

Read More

Posts pagination

1 2
Unveiling the Black Box: Advances and Challenges in Large Language Model ExplainabilityScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921The Aging Atlas: Unlocking the Secrets of Cellular Decline Across Mammalian TissuesAnthropic’s Claude API Deepens Integration with Python Ecosystem, Offering Robust Toolkit for Advanced AI Development
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative diseaseThe oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
YOU MAY HAVE MISSED
Biotech & Genetic Research
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ